Hauptman, Jonathan

XENical in the Prevention of Diabetes in Obese Subjects (XENDOS) Study

Torgerson, J. S., Hauptman, J., Boldrin, M. N., & Sjöström, L. (2004) · Diabetes Care

Pharmacology and Obesity TreatmentBariatric Surgery and Outcomes

Cited by 1,915

Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat: A Randomized Controlled Trial

Davidson, M. H., Hauptman, J., DiGirolamo, M., Foreyt, J. P., Halsted, C. H., Heber, D., Heimburger, D. C., Lucas, C. P., Robbins, D. C., Chung, J., et al. (1999) · JAMA

Pharmacology and Obesity TreatmentBariatric Surgery and Outcomes

Cited by 947

Unimolecular Dual Incretins Maximize Metabolic Benefits in Rodents, Monkeys, and Humans

Finan, B., Ma, T., Ottaway, N., Müller, T. D., Habegger, K. M., Heppner, K. M., Kirchner, H., Holland, J., Hembree, J., Raver, C., et al. (2013) · Science Translational Medicine

Diabetes Treatment and ManagementPancreatic function and diabetes

Cited by 696

Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study

Hollander, P. A., Elbein, S. C., Hirsch, I. B., Kelley, D., McGill, J., Taylor, T., Weiss, S. R., Crockett, S. E., Kaplan, R. A., Comstock, J., et al. (1998) · Diabetes Care

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 654

Effect of Orlistat on Weight and Body Composition in Obese Adolescents: A Randomized Controlled Trial

Chanoine, J.-P., Hampl, S., Jensen, C., Boldrin, M., & Hauptman, J. (2005) · JAMA

Pharmacology and Obesity TreatmentObesity, Physical Activity, Diet

Cited by 624

Orlistat in the long-term treatment of obesity in primary care settings.

Hauptman, J. (2000) · Archives of Family Medicine

Pharmacology and Obesity TreatmentBariatric Surgery and Outcomes

Cited by 367

Effects of weight loss with orlistat on glucose tolerance and progression to type 2 diabetes in obese adults

Heymsfield, S. B., Segal, K. R., Hauptman, J., Lucas, C. P., Boldrin, M. N., Rissanen, A., Wilding, J. P. H., & Sjöström, L. (2000) · Archives of Internal Medicine

Pharmacology and Obesity TreatmentBariatric Surgery and Outcomes

Cited by 358

Orlistat, a lipase inhibitor, for weight maintenance after conventional dieting: a 1-y study.

Hill, J. O., Hauptman, J., Anderson, J. W., Fujioka, K., O'Neil, P. M., Smith, D. K., Zavoral, J. H., & Aronne, L. J. (1999) · The American Journal of Clinical Nutrition

Pharmacology and Obesity TreatmentBariatric Surgery and Outcomes

Cited by 287